Scholars Central

Conference abstractPublished 2 Nov 2015

Gallium tetraphenyl porphyrin nanoparticles: An effective drug candidate against Acinetobacter baumannii in macrophages

Authors: Prabagaran Narayanasamy, Seoung ryoung Choi, Courtney Venegas, Bradley Britigan, Joel Frandsen

1University of Nebraska, USA 2VA-Nebraska Western Iowa Medical Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Acinetobacter baumannii (A. baumannii) is a gram-negative bacterium that has become increasingly resistant to antibiotic treatments and is an important cause of hospital acquired infection. Such infections have most commonly seen in military members and immune suppressed individuals, and can occur as a co-infection with other bacteria. A. baumannii has complex epidemiology and multiple strains, making specific species difficult to distinguish. Its resistance to antibiotics is conferred by several methods, including hydrolyzing antibiotic compounds, efflux pumps, the ability to receive resistance genes from other species, the ability to form biofilms and resistance to desiccation. A. baumannii are often resistant to multiple drugs and are becoming increasingly resistant to most available antibiotics. Hence, finding a novel drug candidate is much needed. Researchers have investigated the ability of gallium (Ga) compounds that interfere with microbial iron metabolism to inhibit the growth of A. baumannii. Ga limits the iron availability significantly and inhibits A. baumannii growth in vitro. In the pursuit of forms of Ga with prolonged activity and ability to reach intracellular sites, our team has found that gallium tetraphenyl porphyrin nanoparticle reduces A. baumannii ATCC 19606 growth at one day in infected THP-1 cells by more than 6 fold. Furthermore, folic acid and mannose tagging of the Ga nanoparticles enhanced drug delivery by engaging specific folic acid and mannose receptors of the macrophage. More importantly, the receptor targeted nanoparticles showed enhanced inhibition of A. baumannii growth relative to the standard Ga nanoparticle, confirming the value of receptor targeting. These data suggest that Ga nanoparticles could provide a novel and prolonged acting therapy for A. baumannii infections.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Medicinal Chemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Prabagaran Narayanasamy”
  • BylineArticles whose byline prints “Seoung ryoung Choi”
  • BylineArticles whose byline prints “Courtney Venegas”
  • BylineArticles whose byline prints “Bradley Britigan”
  • BylineArticles whose byline prints “Joel Frandsen”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels